HPV vaccine

Intradermal, Fractional Dose of HPV Vaccines:

Immunogenicity of Fractional Dose of the HPV Vaccines

Trial to Evaluate Nonavalent HPV Vaccine as a Secondary Prevention in Patients Treated for Human Papilloma Virus Related High-grade Squamous Intraepithelial Lesions

Strengthening HPV Immunization Through EPI Leveraged Delivery

Multiple Human Papillomavirus Infections in the Development of CIN

Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis

Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment

Immunogenicity and Safety of One Dose of HPV Vaccine

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females

A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine

Evaluation of the Implementation and Effectiveness of IPP-HPV

Integration of HPV Vaccination and HPV-based Cervical Screening Into ARV Clinics: the H2VICTORY Trial

Protective Efficacy of HPV Vaccination After Treatment of HPV Related Diseases

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN.

A Phase I Study of Quadrivalent HPV Recombinant Vaccine

Adolescent Vaccination in Pharmacies

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

Immune Response to HPV Vaccine Among HIV-1-infected Subjects in Brazil